| 产品详情 |
| Edit |   |
| Product Name | Suramin (sodium salt) |
| Description | Purity >98%. Suramin is a polysulfonated naphthylurea that inhibits the binding of calmodulin to recognition sites on the ryanodine receptor-1 (IC50 = 4.9 µM), blocks G protein coupling to GPCRs, and non-selectively antagonizes P2 purinergic receptors (10-100 µM). Suramin also acts as a non-specific competitor of glycosaminoglycan binding to a variety of targets including TGFBeta, PDGF, and FGF and additionally inhibits insulin-like growth factor-l, EGF, PKC activity, TNF, IL-2, transferrin, and Apo-B. While originally used as an early stage treatment of trypanosome-caused onchocerciasis (African river blindness) and African trypanosomiasis (African sleeping sickness), suramin has been under clinical evaluation for its potential to regress a number of cancer cell lines, including non-small cell lung cancer, advanced breast cancer, hormone refractory prostate cancer, metastatic renal cell cancer, colorectal cancer, and high-grade gliomas. |
| Size | n/a |
| Concentration | n/a |
| Applications | n/a |
| Other Names | 8,8'-[carbonylbis[imino-3,1-phenylenecarbonylimino(4-methyl-3,1-phenylene)carbonylimino]]bis -1,3,5-naphthalenetrisulfonic acid, hexasodium salt, Germanin, BAY 205, NF 060 |
| Gene, Accession, CAS # | CAS: 129-46-4 |
| Catalog # | LS-H10076 |
| Price | |
| Order / More Info | Suramin (sodium salt) from LIFESPAN BIOSCIENCES INC. |
| Product Specific References | n/a |
| 产品资料 |
|
|